8-Carboxamidocyclazocine
A chemical compound related to cyclazocine
| Chemical Compound | |
|---|---|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider ID | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| Properties | |
| Chemical Formula | |
| Molar Mass | |
| Appearance | |
| Density | |
| Melting Point | |
| Boiling Point | |
| Hazards | |
| GHS Pictograms | [[File:|50px]] |
| GHS Signal Word | |
| GHS Hazard Statements | |
| NFPA 704 | [[File:|50px]] |
| References | |
8-Carboxamidocyclazocine is a chemical compound that belongs to the class of benzomorphan opioids. It is structurally related to cyclazocine, a well-known opioid receptor agonist and antagonist.
Chemical structure and properties[edit]
8-Carboxamidocyclazocine is a derivative of cyclazocine, characterized by the presence of a carboxamide group at the 8-position of the benzomorphan skeleton. This modification alters its binding affinity and activity at various opioid receptors.
Pharmacology[edit]
8-Carboxamidocyclazocine acts as a kappa-opioid receptor agonist and a mu-opioid receptor partial agonist. The kappa-opioid receptor activity is associated with its potential analgesic effects, as well as its ability to produce dysphoria and hallucinations in some cases. The mu-opioid receptor activity contributes to its analgesic properties but also limits its use due to potential for abuse and dependence.
Potential therapeutic uses[edit]
Research into 8-Carboxamidocyclazocine has focused on its potential as an analgesic with reduced abuse potential compared to traditional mu-opioid receptor agonists. Its kappa-opioid receptor activity may also make it useful in treating conditions such as depression and anxiety, although these applications are still under investigation.
Side effects and safety[edit]
As with other kappa-opioid receptor agonists, 8-Carboxamidocyclazocine may cause side effects such as dysphoria, hallucinations, and sedation. Its safety profile is not fully established, and further research is needed to determine its long-term effects and potential for abuse.
Related pages[edit]
-
8-Carboxamidocyclazocine
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
